FY27 is shaping up as an inflection year for Jubilant Ingrevia, with contract development manufacturing organisation ramp-up, improving nutrition mix and operating leverage across newly commissioned assets, says the brokerage.
FY27 is shaping up as an inflection year for Jubilant Ingrevia, with contract development manufacturing organisation ramp-up, improving nutrition mix and operating leverage across newly commissioned assets, says the brokerage.
<iframe src="https://hindustansphere.com/embed/cluster/6988ccb5067cf9e1924f6a6e676085a9b428f02b" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Jubilant Ingrevia Shares In Focus: Anand Rathi Bets On Earnings Inflection — Buy, Sell or Hold?"></iframe>
